Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000271099 refers to a **pseudogene** of the Poly(A) binding protein, cytoplasmic 4 (PABPC4), also called the inducible form[1][4][10]. Unlike protein-coding genes, pseudogenes do not produce functional proteins and generally lack biological activity; therefore, this locus is not considered a therapeutic target, receptor, enzyme, transporter, or similar molecule[1][4]. The functional Poly(A) binding protein, cytoplasmic 4 (PABPC4), is involved in mRNA regulation and immune cell activation, but the pseudogene does not share this role[1][2][5]. No drug interactions, disease associations, or biomarker or safety profiles are associated with this pseudogene. **Key Note:** - This entry is a **pseudogene**, not a functional protein-coding gene or molecular target[1][4][10]. - There is no evidence for the pseudogene being involved in disease, therapy, or as a biomarker. - If a therapeutic target is intended, the request should refer to PABPC4 (the functional gene/protein), not its pseudogene[2][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Poly(A) binding protein, cytoplasmic 4 (inducible form) pseudogene.